Undetectable PSA predicts outcome after salvage radiotherapy for biochemical recurrence following radical prostatectomy
Authors:
Open Access
- 13 August 2024
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 200, 110476
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical ProstatectomyJAMA Network Open, 2023
- Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical ProstatectomyEuropean Urology Oncology, 2022
- Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 TrialEuropean Urology, 2021
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentEuropean Urology, 2021
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate CancerEuropean Urology, 2021
- A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerEuropean Urology, 2018
- 68Ga‐PSMA‐PET for radiation treatment planning in prostate cancer recurrences after surgery: Individualized medicine or new standard in salvage treatmentThe Prostate, 2017
- Psychological effects of androgen‐deprivation therapy on men with prostate cancer and their partnersCancer, 2015
- Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate ThemEuropean Urology, 2015
- Prediction of Outcome Following Early Salvage Radiotherapy Among Patients with Biochemical Recurrence After Radical ProstatectomyEuropean Urology, 2014